BAT Announces £25 Billion Write-down, Stock Price Plummeting by 10.2%

BAT by 2FIRSTS.ai
Dec.07.2023
BAT Announces £25 Billion Write-down, Stock Price Plummeting by 10.2%
British American Tobacco (BAT) announces a £25 billion write-down due to the reassessment of its tobacco brands in the US.

According to a Reuters report on December 6th, British American Tobacco announced that it expects to incur a write-down loss of approximately £25 billion ($31.5 billion) due to the reassessment of the value of certain tobacco brands in the United States.

 

Following the release of the news, the stock price of British American Tobacco (BAT) experienced a decline of 10.2% in London, reaching its lowest level since September 2010. Tobacco stocks listed in the United States were also affected. The stock price of Altria Group Inc. (MO.N) fell by 3.4%, while Philip Morris International Inc. (PM.N) saw a decrease of 2.1%.

 

British American Tobacco has stated that the challenging environment in the United States, particularly the weak economy and the widespread popularity of illegal disposable e-cigarettes, has had a negative impact on its business and could potentially weigh down its growth in 2023 and 2024.

 

British American Tobacco (BAT) has reported non-cash impairment losses of £25 billion as a result of economic challenges affecting its US operations and a shift by some consumers to cheaper brands due to "fatigue".

 

British American Tobacco (BAT) stated in its updated financial report preview that "this accounting adjustment primarily involves some American combustible tobacco brands we acquired, as we now evaluate their book value and estimated useful life to be around 30 years.

 

The company added that it will begin amortizing the remaining value of its combustible tobacco brand in the United States starting in 2024.

 

British American Tobacco (BAT) is maintaining its full-year revenue forecast for 2023, expecting a solid organic growth of 3-5% at fixed exchange rates. However, due to mounting pressure in the US and plans to increase investment in new products such as e-cigarettes and nicotine pouches, the growth might be towards the lower end of this range.

 

The company also stated that these factors imply that projected revenue and adjusted operating profit growth for 2024 will be in the low single digits.

 

Erika Swore, Vice President of National Communications at the American Lung Association, stated in a press release, "No one should profit from death and disease.

 

Further Reading:

 

A write-down is an accounting term that refers to a company reducing the book value of an asset because it believes that the market value or future cash flows of the asset are lower than its previous book value. This adjustment typically occurs when a company no longer expects certain assets it holds to generate the anticipated economic benefits as previously estimated.

 

In financial statements, companies may write down the carrying value of their assets to their current estimated market value or future cash flow levels. This can include fixed assets, inventory, intangible assets, or other investments.

 

Budget cuts are typically caused by a variety of factors, including:

 

Market devaluation: The value of assets in the market decreases, requiring a readjustment of their book value. Technological obsolescence: For assets that rapidly become outdated due to the emergence of new technologies, companies may write down their value. Economic downturn: In times of economic recession, certain assets may be unable to generate the expected economic value and therefore require a write-down.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product|PMI Expands High-Strength Nicotine Pouch Portfolio With Zyn 16.5mg
Product|PMI Expands High-Strength Nicotine Pouch Portfolio With Zyn 16.5mg
According to Better Retailing, Philip Morris International (PMI) has launched Zyn Menthol Ice 16.5mg in the UK, marking the highest-strength nicotine pouch in the Zyn range to date. The eucalyptus- and menthol-flavored product is now available through PMI Open and will begin rolling out to wholesale channels from the end of May.
PMI
May.28
 BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
British American Tobacco’s London-listed shares rose 13.99% last week, as investors focused on the U.S. Food and Drug Administration’s recent authorization of flavored Glas e-cigarette products, the dismissal of a U.S. sanctions-related criminal case against BAT, and the company’s previously announced share buyback plan and newer nicotine business performance.
BAT
May.18
New Movement Emerges on EU Tobacco Excise Directive as Cyprus Tables Compromise Draft
New Movement Emerges on EU Tobacco Excise Directive as Cyprus Tables Compromise Draft
The long-stalled debate over the European Union’s Tobacco Excise Directive may be moving forward, with Cyprus, as holder of the EU Council presidency, putting forward a compromise draft. The reported proposal includes lowering the minimum excise duty requirement and granting a transitional period, with the aim of reaching political agreement by June 2026. The revision also covers e-cigarettes, heated tobacco, nicotine pouches and stronger controls on raw tobacco.
Apr.21 by 2FIRSTS.ai
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
The U.S. Food and Drug Administration (FDA) announced on May 5, 2026 that it authorized the marketing of four Glas electronic nicotine delivery system (ENDS) products through the premarket tobacco product application (PMTA) pathway. The authorized products are Classic Menthol, Fresh Menthol, Gold and Sapphire pods, each containing 50mg/ml, or 5%, tobacco-derived nicotine.
May.06 by 2FIRSTS.ai
RJR Vapor Loses Tax Refund Case as Texas High Court Finds VELO Pouches Taxable
RJR Vapor Loses Tax Refund Case as Texas High Court Finds VELO Pouches Taxable
The Texas Supreme Court issued a case summary on May 8, 2026, describing its decision in Hancock v. RJR Vapor Co. LLC. The dispute centered on whether RJR Vapor’s VELO oral nicotine pouches are taxable as “tobacco products” under the Texas Tax Code. Lower courts had held that the pouches were not taxable tobacco products, but the Texas Supreme Court reversed, concluding that VELO pouches are taxable because they are made of “a tobacco substitute.”
May.09 by 2FIRSTS.ai